ClinicalTrials.Veeva

Menu

25OH Vitamin D Overdoses and Risk of Bronchopulmonary Dysplasia or Death (25OHVDORBPDD)

Civil Hospices of Lyon logo

Civil Hospices of Lyon

Status

Enrolling

Conditions

Vitamin D Overdose
Bronchopulmonary Dysplasia

Treatments

Biological: Is 25 OH vitamin D overdose a risk factor of bronchopulmonary dysplasia or death ?

Study type

Observational

Funder types

Other

Identifiers

NCT05944055
69HCL23_0244

Details and patient eligibility

About

Several studies have demonstrated that vitamin D deficiency at birth is a risk factor of bronchopulmonary dysplasia. However, in an animal model of bronchopulmonary dysplasia vitamin D overdose has also been associated with an increased mortality and an increased lung injury. Such vitamin D overdose has been frequently reported in hospitalized neonates receiving the current supplementation.

The hypothesis is that vitamin D overdose is an independent risk factor of bronchopulmonary dysplasia or death among infants born below 31 weeks gestational age excluding infants with vitamin D deficiency.

This retrospective cohort study will include all infants born before 31 weeks of gestation (WG), who were hospitalized in a tertiary neonatal intensive care unit (NICU) during at least 10 days, for who at least one 25OH vitamin D determination was performed before 36 WG corrected age and whose parents are not opposed to the study. A descriptive analysis of the cohort depending on the occurrence of vitamin D overdose will be performed. A multivariate analysis will determine if vitamin D overdose is an independent risk factor of bronchopulmonary dysplasia or death among preterm infants, adjusting on the covariates known to be associated with bronchopulmonary dysplasia.

Enrollment

173 estimated patients

Sex

All

Ages

23 to 31 weeks old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Inclusion Criteria * :
  • Infant born before 31 weeks of gestation.
  • hospitalized in the NICU during at least 10 days
  • with at least a 25OH-D determination available before 36 weeks corrected age

Exclusion criteria

-Infant with at least a 25OH-D below 50 nmol/L

Trial design

173 participants in 2 patient groups

Overdose
Description:
Preterm born before 31 weeks of gestation with at least a 25OH-D measure above 120nmol/L before 36 weeks corrected age and no determination below 50nmol/L. Of note, 25OH-D determinations are routinely performed each month from the first month of life during the NICU hospitalization
Treatment:
Biological: Is 25 OH vitamin D overdose a risk factor of bronchopulmonary dysplasia or death ?
Control
Description:
Preterm infants born before 31 weeks of gestation, who presented with a 25OH-D between 50 and 120nmol/L for all the 25OH-D measures during their hospitalization in the NICU setting. Of note, 25OH-D determinations are routinely performed each month from the first month of life during the NICU hospitalization
Treatment:
Biological: Is 25 OH vitamin D overdose a risk factor of bronchopulmonary dysplasia or death ?

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems